Past efforts have demonstrated that miR-9-5p and FOXO1 were involved in the progression of HCC in vivo [14,15,30] and CPEB3 silencing increased tumor size and weight in HCC [28]. The gene discussed is CPEB3; the disease is hepatocellular carcinoma.